About
CDMO
Areas of Focus
Categories
Contract ManufacturingContract ManufacturingContract ManufacturingContract ManufacturingContract ResearchContract ManufacturingNJ, NY, PA
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
540
By Phase
PHASE1: 1PHASE2: 2PHASE3: 1PHASE1/PHASE2: 1
By Status
TERMINATED: 4COMPLETED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
Today
Hover over trial bars to see details
Recent Trials
NCT00982215Collaborator
Pilot Study of Pharmacology of Paracetamol Administered Per-oral Mucosa
PHASE1Completed
20 participants
Started: Sep 30, 2009 · Completed: Oct 31, 2009
NCT00086632Lead Sponsor
Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment
PHASE2Terminated
40 participants
Started: Jul 31, 2004 · Completed: Dec 31, 2007
NCT00050375Lead Sponsor
Clinical Trial for Ovarian Cancer (OvaRex®)
PHASE3Terminated
354 participants
Started: Dec 31, 2002 · Completed: Dec 31, 2007
NCT00034138Lead Sponsor
A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma
PHASE1/PHASE2Terminated
24 participants
Started: Mar 31, 2002 · Completed: Dec 31, 2007
NCT00034372Lead Sponsor
Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma
PHASE2Terminated
102 participants
Started: Sep 30, 2000 · Completed: Dec 31, 2007
Locations (1)
Headquarters
Rochester, NY, United States
Map
Loading map...